X4 CRT-D System
X4 CRT-D and ACUITYᵀᴹ X4 Quadripolar Pacing Leads
Effectively Pace for years with the industry’s longest-lasting CRT-D
Reduce Risks of CRT-D Replacements
Manufacturer’s Product Performance Reports show a clinically meaningful difference in device survival.
Medtronic and Boston Scientific Actual Product Performance Report Data
|BSC COGNIS CRT-D||100%||99.9%||99.8%||99.5%||98.7%||97.2%||94.1%|
|MTD Concerto CRT-D DR||100%||99.6%||98.2%||93.5%||80.6%||51.4%||23.0%|
|MTD Consulta CRT-D DR||100%||99.7%||98.5%||93.5%||81.8%||60.8%||43.4%
out by 72 months.1
1.9 Ah battery
out by 72 months.2
1 Ah Battery
out by 66 months.3
1 Ah Battery
Confidence in longevity
Confidence in our Longevity. Built on the industry's longest-lasting battery technology, X4 CRT-D offers a projected longevity of 8.1 years backed by corporate warrenty.2,3
Boston Scientific supports our longevity claims with our commercial offering of our corporate warranty.
An independent study of contemporary heart failure devices released in October 2013 by EP EuroPace highlights industry-leading Boston Scientific battery longevity.
Real world data from LATITUDE Patient Management shows a nine-year average projected longevity of our CRT-Ds.
View our Product Performance Reports